Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Management of Sinus Tachycardia and Premature Atrial Contractions

Diagnosis and Evaluation

  • The American College of Cardiology recommends ruling out secondary causes of sinus tachycardia, including stimulants, medications, recreational drugs, medical conditions, and emotional stress and anxiety-related disorders 1
  • Ambulatory monitor results can show normal sinus rhythm with average heart rate, presence of PACs, and episodes of SVT, which can help diagnose sinus tachycardia and PACs 1

Treatment

  • The American College of Cardiology recommends beta blockers as first-line therapy for symptomatic patients with sinus tachycardia and PACs, as they are extremely useful and effective for symptomatic sinus tachycardia 1
  • Alternative therapy with non-dihydropyridine calcium channel blockers, such as verapamil or diltiazem, can be considered if beta blockers are contraindicated 1
  • Reducing or eliminating stimulants and addressing anxiety and stress through appropriate interventions can also be beneficial 2

Treatment Goals and Outcomes

  • The goal of treatment should be symptom reduction rather than just rate control, as lowering heart rate may not always alleviate symptoms 2
  • Follow-up ambulatory monitoring can assess treatment efficacy and evaluate both symptom improvement and heart rate control 1

Prognosis and Complications

  • The prognosis for patients with sinus tachycardia is generally benign, with a small risk of tachycardia-induced cardiomyopathy in untreated patients 1
  • Proper differentiation between physiological sinus tachycardia, inappropriate sinus tachycardia, and other arrhythmias is essential to avoid misdiagnosis 1, 2

Special Considerations

  • A significant proportion of patients with palpitations have underlying anxiety disorders that should be addressed 1
  • Frequent PACs are associated with an increased risk of developing atrial fibrillation, and therefore, PACs are not always benign 1